70 related articles for article (PubMed ID: 26238298)
1. Duloxetine in treating generalized anxiety disorder in adults: A meta-analysis of published randomized, double-blind, placebo-controlled trials.
Zhang Y; Huang G; Yang S; Liang W; Zhang L; Wang C
Asia Pac Psychiatry; 2016 Sep; 8(3):215-25. PubMed ID: 26238298
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta-analysis.
Kishi T; Sakuma K; Hatano M; Okumura T; Kato M; Baba H; Iwata N
Neuropsychopharmacol Rep; 2024 Mar; 44(1):267-271. PubMed ID: 38318955
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of patient education and duloxetine, alone and in combination, for patients with multisystem functional somatic disorder: Study protocol for the EDULOX trial.
Jespersen CP; Pedersen HF; Kleinstäuber M; Fink P; Wellnitz KB; Ørnbøl E; Schröder A; Agger JL; Vase L; Finnerup NB; Gormsen LK
Contemp Clin Trials; 2024 Jun; 141():107524. PubMed ID: 38604496
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine in the treatment of generalized anxiety disorder.
Wright A; Vandenberg C
Int J Gen Med; 2009 Dec; 2():153-62. PubMed ID: 20360899
[TBL] [Abstract][Full Text] [Related]
5. Tolerability and efficacy of duloxetine for the prevention of persistent musculoskeletal pain after trauma and injury: a pilot three-group randomized controlled trial.
Beaudoin FL; Gaither R; DeLomba WC; McLean SA
Pain; 2023 Apr; 164(4):855-863. PubMed ID: 36375173
[TBL] [Abstract][Full Text] [Related]
6. The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials.
Rossano F; Caiazza C; Zotti N; Viacava L; Irano A; Solini N; Pistone L; Pezone R; Cilmi F; Ricci C; De Prisco M; Iasevoli F; Kishi T; Solmi M; de Bartolomeis A; Fornaro M
Eur Neuropsychopharmacol; 2023 Nov; 76():23-51. PubMed ID: 37544075
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the comparative efficacy of benzodiazepines and antidepressants for psychic versus somatic symptoms of generalized anxiety disorder.
Beyer C; Currin CB; Williams T; Stein DJ
Compr Psychiatry; 2024 Jul; 132():152479. PubMed ID: 38564872
[TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Antidepressants for generalised anxiety disorder (GAD).
Kapczinski F; dos Santos Souza JJ; Batista Miralha da Cunha AA; Schmitt RR
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD003592. PubMed ID: 26963371
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and network meta-analysis of agomelatine for the treatment of generalized anxiety disorder in adult patients.
Hood SD; Odufowora-Sita O; Briere JB; Lucchino M; Khrouf F; Olewinska E; Pierzchala P; Mezghani M; Nikodem M; Lévy P
Int Clin Psychopharmacol; 2024 May; ():. PubMed ID: 38804215
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine may have clinical value: comment on the article by van den Driest et al.
Block JA; Pincus T
Arthritis Rheumatol; 2022 Nov; 74(11):1859-1860. PubMed ID: 35791999
[No Abstract] [Full Text] [Related]
11. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
[TBL] [Abstract][Full Text] [Related]
12. A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain.
King JB; Schauerhamer MB; Bellows BK
Ther Clin Risk Manag; 2015; 11():1163-75. PubMed ID: 26309404
[TBL] [Abstract][Full Text] [Related]
13. Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent.
Wang SM; Lee HK; Kweon YS; Lee CT; Lee KU
Clin Psychopharmacol Neurosci; 2015 Aug; 13(2):212-4. PubMed ID: 26243851
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
Murakami M; Osada K; Mizuno H; Ochiai T; Alev L; Nishioka K
Arthritis Res Ther; 2015 Aug; 17(1):224. PubMed ID: 26296539
[TBL] [Abstract][Full Text] [Related]
15. Topical diclofenac therapy for osteoarthritis: a meta-analysis of randomized controlled trials.
Deng ZH; Zeng C; Yang Y; Li YS; Wei J; Yang T; Li H; Lei GH
Clin Rheumatol; 2016 May; 35(5):1253-61. PubMed ID: 26242469
[TBL] [Abstract][Full Text] [Related]
16. The noradrenergic paradox: implications in the management of depression and anxiety.
Montoya A; Bruins R; Katzman MA; Blier P
Neuropsychiatr Dis Treat; 2016; 12():541-57. PubMed ID: 27042068
[TBL] [Abstract][Full Text] [Related]
17. Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches.
Coplan JD; Aaronson CJ; Panthangi V; Kim Y
World J Psychiatry; 2015 Dec; 5(4):366-78. PubMed ID: 26740928
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures.
Huang X; Wang P; Tal R; Lv F; Li Y; Zhang X
Int J Gynaecol Obstet; 2015 Nov; 131(2):111-6. PubMed ID: 26304048
[TBL] [Abstract][Full Text] [Related]
19. Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.
Gommoll C; Forero G; Mathews M; Nunez R; Tang X; Durgam S; Sambunaris A
Int Clin Psychopharmacol; 2015 Nov; 30(6):297-306. PubMed ID: 26291335
[TBL] [Abstract][Full Text] [Related]
20. Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale.
Montejo AL; Deakin JF; Gaillard R; Harmer C; Meyniel F; Jabourian A; Gabriel C; Gruget C; Klinge C; MacFayden C; Milligan H; Mullings E; Goodwin G
J Psychopharmacol; 2015 Oct; 29(10):1119-28. PubMed ID: 26268533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
